ImprimisRx CA, Inc., dba ImprimisRx recalls Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a l

Recalled September 13, 2017 · FDA recall D-1133-2017 · ImprimisRx CA, Inc.,

Hazard

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier · FDA Class II

Units

2 bottles

Sold at

Nationwide

Description

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Product

Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA

Manufacturer(s)

ImprimisRx CA, Inc., dba ImprimisRx

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →